Trial management support

Provided by EUROPEAN CLINICAL RESEARCH INFRASTRUCTURES NETWORK (ECRIN)

ECRIN

• trial management operations (interaction with competent authorities & ethics committees, project management, monitoring, vigilance, data management)
• clinical trial tools (outcome measures, regulatory database, site locations, risk-based monitoring)

Visit website

Transnational access Calls focussed on pathogenic agents

Provided by EUROPEAN RESEARCH INFRASTRUCTURE ON HIGHLY PATHOGENIC AGENTS (ERINHA)

Erinha

To facilitate Transnational access (TNA) to ERINHA’s member facilities, ERINHA periodically opens a call for applications. Free of charge TNA includes administrative & logistical support, remote use of ERINHA high containment facilities, and technical & scientific support.
Transnational Access is either:
– In person/on-site, and provided to selected Users that visit the facilities, on the necessary conditions that the users have appropriate background and successfully complete the required training
– Remote, through the provision of remote scientific services to selected Users
Note: Remote access will systematically apply for in vivo experiments

Visit website

Biosafety and biosecurity expertise

Provided by EUROPEAN RESEARCH INFRASTRUCTURE ON HIGHLY PATHOGENIC AGENTS (ERINHA)

Erinha

Access to high containment, biosafety and biosecurity expertise.
ERINHA’s senior scientists and experts in biosafety and biosecurity with long-standing experience in operating and maintaining biocontainment facilities (BSL4 and complementary) provide expertise on:
• Development of research programs on high-consequence pathogens
• Developing risk assessments
• Building and operating a high containment facility
• Designing and implementing a biosafety program
• Other expertise related to high containment research facilities

Visit website

Training on technologies, methodological and computer skills

Provided by IFB - FRENCH INSTITUTE OF BIOINFORMATICS

france bioinformatique

IFB provides IFB users (biologists, biomedical and bioinformaticians) with a training offer that takes into account the wide diversity of needs and expectations:

– diversity of computer skills (no command line experience, occasional use, familiar, program a little)
– specific courses on new technologies or on biological applications (e.g. NGS, long reads, metabolomics…)
– generic methodological skills (statistics, good programming practices, etc.)
– advanced use of IT technologies (HPC, virtualisation, cloud computing, interoperability, FAIR practices, integrative bioinformatics…)
– good training practices (pedagogical approaches, reuse of materials, etc.)

Visit website

Directory of professionals and expert centers

Provided by ORPHANET

ORPHANET

Orphanet provides information on professionals whose activity(ies) in the field of rare diseases is (are) registered in Orphanet. This includes, for example, consultant and physicians in charge of an expert centre, biologists in a laboratory, researchers, representatives of patient organisations, coordinators of networks, principal investigators of clinical trials, managers or contact person of registries and biobanks, and experts writing or peer-reviewing data for Orphanet.

Visit website

RaDiCo supports the implementation of national programs in any country that would need it, by sharing its expertise in database management and implementation of national cohorts on rare diseases. Beyond its own projects, RaDiCo promotes the commitment of French actors to European and international projects needing the implementation of borderless cohorts. We advise and support you for the setting up of propositions and for the management of your programs in this field..).

Visit website

Paediatric clinical trial management

Provided by PedCRIN

PEDCRIN

PedCRIN developed a series of tools (WP3) and procedures to support the setup and the management of multinational neonatal and paediatric clinical trials in Europe. These tools are developed to train and support researchers and clinicians so they can establish, run, and manage both paediatric and neonatal multinational clinical trials in a more effective and easier way. The removal of barriers to trial management will speed up the evaluation of new and improved therapies.

Visit website